MedTrace Logo

Adherence to Lumefantrine-Artemether

NCT00153491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2005-09-12

No results posted yet for this study

Summary

This is a study of how well caregivers of children with malaria adhere to the recommended regimen for lumefantrine-artemether (LA). Children were randomly assigned to either a group receiving directly observed treatment in hospital or to a group treated at home by the routine caregiver (typically, patient's mother). Clinical/parasitologic, hematologic, pharmacologic and qualitative parameters were monitored over a 28-day follow-up period and are used to evaluate drug adherence.

Conditions

  • Malaria, Uncomplicated

Interventions

DRUG

artemether-lumefantrine

Sponsors & Collaborators

Principal Investigators

  • Louise Causer, MBBS, MScPH · Centers for Disease Control and Prevention

  • Salim Abdulla, MD, PhD · Ifakara Health Research and Development Centre

  • Peter B Bloland, DVM, MPVM · Centers for Disease Control and Prevention

  • Stephen P Kachur, MD, MPH · Centers for Disease Control and Prevention

Eligibility

Min Age
0 Years
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2006-08-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153491 on ClinicalTrials.gov